Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations

Objective: To develop and validate a stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) assay for the determination of phenytoin in bulk and pharmaceutical dosage forms. Methods: A HPLC instrument incorporating aZorbaxC-18 analytical column (250x4.6 mm, 5μm particle...

Full description

Saved in:
Bibliographic Details
Main Authors: Teo, S.Y., Rathbone, M.J., Coombes, A.G.A., Lee, S.Y., Gan, S.N.
Format: Article
Published: Innovare Academics Sciences Pvt. Ltd 2015
Subjects:
Online Access:http://eprints.um.edu.my/19567/
https://innovareacademics.in/journals/index.php/ijpps/article/view/6049/6861
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.19567
record_format eprints
spelling my.um.eprints.195672018-10-03T05:56:55Z http://eprints.um.edu.my/19567/ Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations Teo, S.Y. Rathbone, M.J. Coombes, A.G.A. Lee, S.Y. Gan, S.N. Q Science (General) QD Chemistry R Medicine RS Pharmacy and materia medica Objective: To develop and validate a stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) assay for the determination of phenytoin in bulk and pharmaceutical dosage forms. Methods: A HPLC instrument incorporating aZorbaxC-18 analytical column (250x4.6 mm, 5μm particles) with a mobile phase comprising acetonitrile: water in the ratio 50:50 (%v/v) was employed for the determination of phenytoin. The flow rate was set with an isocratic program, the temperature of the column was maintained at 25 °C and a detection wavelength of 200 nm was employed using an ultraviolet detector. The method was validated as per The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines. Results: Total chromatographic analysis time per sample was 6 min with phenytoin eluting with the reaction time of 4.6±0.2 min. Phenytoin was exposed to acidic, basic, oxidative, photolytic and thermal stress conditions and the specificity of the assay was confirmed. The calibration plot was linear (R2≥0.999) over the phenytoin concentration range 5.0-100.0μg/ml. The percentage means recoveries were found to be in the range of 98- 102%. The relative standard deviation of precision and robustness were within prescribed limits (<2%). The limit of detection was 0.047 μg/ml while the limit of quantitation was established as 0.143 μg/ml. Conclusion: A simple, accurate, precise and stability-indicating RP-HPLC assay was successfully developed for the determination of phenytoin in bulk and dosage forms. Hence, this assay is useful for the analysis of phenytoin in formulations in medicines development and pharmaceutical manufacturing setting. Innovare Academics Sciences Pvt. Ltd 2015 Article PeerReviewed Teo, S.Y. and Rathbone, M.J. and Coombes, A.G.A. and Lee, S.Y. and Gan, S.N. (2015) Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations. International Journal of Pharmacy and Pharmaceutical Sciences, 7 (8). pp. 258-263. ISSN 0975-1491 https://innovareacademics.in/journals/index.php/ijpps/article/view/6049/6861
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic Q Science (General)
QD Chemistry
R Medicine
RS Pharmacy and materia medica
spellingShingle Q Science (General)
QD Chemistry
R Medicine
RS Pharmacy and materia medica
Teo, S.Y.
Rathbone, M.J.
Coombes, A.G.A.
Lee, S.Y.
Gan, S.N.
Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
description Objective: To develop and validate a stability-indicating reversed phase high performance liquid chromatography (RP-HPLC) assay for the determination of phenytoin in bulk and pharmaceutical dosage forms. Methods: A HPLC instrument incorporating aZorbaxC-18 analytical column (250x4.6 mm, 5μm particles) with a mobile phase comprising acetonitrile: water in the ratio 50:50 (%v/v) was employed for the determination of phenytoin. The flow rate was set with an isocratic program, the temperature of the column was maintained at 25 °C and a detection wavelength of 200 nm was employed using an ultraviolet detector. The method was validated as per The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines. Results: Total chromatographic analysis time per sample was 6 min with phenytoin eluting with the reaction time of 4.6±0.2 min. Phenytoin was exposed to acidic, basic, oxidative, photolytic and thermal stress conditions and the specificity of the assay was confirmed. The calibration plot was linear (R2≥0.999) over the phenytoin concentration range 5.0-100.0μg/ml. The percentage means recoveries were found to be in the range of 98- 102%. The relative standard deviation of precision and robustness were within prescribed limits (<2%). The limit of detection was 0.047 μg/ml while the limit of quantitation was established as 0.143 μg/ml. Conclusion: A simple, accurate, precise and stability-indicating RP-HPLC assay was successfully developed for the determination of phenytoin in bulk and dosage forms. Hence, this assay is useful for the analysis of phenytoin in formulations in medicines development and pharmaceutical manufacturing setting.
format Article
author Teo, S.Y.
Rathbone, M.J.
Coombes, A.G.A.
Lee, S.Y.
Gan, S.N.
author_facet Teo, S.Y.
Rathbone, M.J.
Coombes, A.G.A.
Lee, S.Y.
Gan, S.N.
author_sort Teo, S.Y.
title Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
title_short Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
title_full Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
title_fullStr Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
title_full_unstemmed Development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
title_sort development and validation of a stability-indicating isocratic reverse phase-liquid chromatography assay for determination of phenytoin in bulk and pharmaceutical formulations
publisher Innovare Academics Sciences Pvt. Ltd
publishDate 2015
url http://eprints.um.edu.my/19567/
https://innovareacademics.in/journals/index.php/ijpps/article/view/6049/6861
_version_ 1643691025351311360
score 13.211869